作者: Kailong Lin , Jianan Cheng , Tao Yang , Yongsheng Li , Bo Zhu
DOI: 10.1016/J.BBRC.2015.05.030
关键词: Gefitinib 、 Lung cancer 、 Targeted therapy 、 Wild type 、 Epidermal growth factor receptor 、 PD-L1 、 Immunotherapy 、 Cancer research 、 Medicine 、 CTLA-4
摘要: … Collectively, these data indicate that NF-κB is required for the elevated PD-L1 expression in … expression of PD-L1 by gefitinib was dependent on NF-κB, we examined the NF-κB activity …